All HIV-1 strains studied to date use CCR5, CXCR4, or both receptors to ent
er cells, Simian immunodeficiency virus (SIV) infection of non-human primat
es has served as a useful model for understanding AIDS pathogenesis in huma
ns. Research on several genetically divergent SIV isolates has revealed tha
t SIV uses CCR5, and not CXCR4, for entry. CEMx174, a human lymphoid cell l
ine, has been routinely used to cultivate and maintain various SIV strains,
However, questions have arisen about how CEMx174, which reportedly was una
ble to express detectable amounts of CCR5 transcripts, efficiently supports
the growth of SIV. In searching for an answer, we resorted to a sensitive
competitive reverse transcriptase-polymerase chain reaction procedure in an
attempt to detect as well as quantify the amount of CCR5 expression. Here
we present our findings, which indicate that CEMx174 indeed expresses CCR5
and that the amount of CCR5 is increased in cells pretreated with morphine.
These results correlate well with our previous observations that morphine
treatment causes CEMx174 cells to be more susceptible to SIV infection, Sim
ilar morphine effect was not observed on CEMx174 cells infected with simian
retroviruses, which do not depend on CCR5 for entry. These findings sugges
t a plausible mechanism whereby opiate drug users render themselves more su
sceptible to HIV infection, thereby explaining the vast prevalence of HIV i
nfection among endemic drug use populations.